betacatpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Iterion |
| Description | About Technology Our Programs Collaborations News Publications Contact Us Bringing novel therapies to patients most in need Transducin Beta-like Protein 1 |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 15.197.142.173 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
betacatpharma.com Valuation
|
US$1,124
Last updated: 2022-08-19 23:20:11
betacatpharma.com has Semrush global rank of 0. betacatpharma.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. betacatpharma.com receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 15.197.142.173. According to SiteAdvisor, betacatpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,124 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$31 |
| Yearly Ads Revenue | US$373 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| betacatpharma.com. | A | 599 | IP: 15.197.142.173 |
| betacatpharma.com. | A | 599 | IP: 3.33.152.147 |
| betacatpharma.com. | NS | 3600 | NS Record: ns32.domaincontrol.com. |
| betacatpharma.com. | NS | 3600 | NS Record: ns31.domaincontrol.com. |
| betacatpharma.com. | MX | 3600 | MX Record: 0 betacatpharma-com.mail.protection.outlook.com. |
| betacatpharma.com. | TXT | 3600 | TXT Record: MS=ms25936329 |
| betacatpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-08-19 23:20:11
| About Technology Our Programs Collaborations News Publications Contact Us Bringing novel therapies to patients most in need Transducin Beta-like Protein 1 (TBL1), a key regulator of oncogenic signaling pathways. Iterion Therapeutics Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics. The company’s lead product, tegavivint, is a potent and selective small molecule inhibitor of Transducin Beta-Like Protein 1 (TBL1), a downstream target in the Wnt/beta-catenin pathway. Wnt-signaling inhibition offers enormous therapeutic potential, but prior inhibitors have been plagued by toxicity issues, greatly limiting their clinical use. Tegavivint unique mechanism of action has the potential to overcome these challenges. Binding of TBL1 to beta-catenin in the nucleus is necessary for activation of beta-catenin-dependent gene transcription. Tegavivint binds to TBL1 preventing the TBL1/beta-catenin complex from forming and |
HTTP Headers
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Mon, 20 Dec 2021 02:32:36 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
betacatpharma.com Whois Information
Domain Name: BETACATPHARMA.COM Registry Domain ID: 1621140963_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-10-20T14:26:40Z Creation Date: 2010-10-19T14:47:10Z Registry Expiry Date: 2022-10-19T14:47:10Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS31.DOMAINCONTROL.COM Name Server: NS32.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |